Valmark Advisers’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$390K Sell
1,643
-469
-22% -$97.5K ﹤0.01% 561
2026
Q1
$446K Buy
2,112
+427
+25% +$92K 0.01% 493
2025
Q4
$346K Buy
1,685
+6
+0.4% +$1.13K ﹤0.01% 526
2025
Q3
$264K Hold
1,679
﹤0.01% 584
2025
Q2
$282K Buy
+1,679
New +$249K ﹤0.01% 563

Other funds holding CAH

Valmark Advisers's CAH Position: Q2 2026 in Review

Valmark Advisers reduced its Cardinal Health (CAH) stake by 22% in Q2 2026, selling an estimated $97.5K and leaving 1,643 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #561.

Valmark Advisers first reported a position in CAH in Q2 2025 and has held it in 5 quarters since. The position peaked at $446K in Q1 2026. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Valmark Advisers held 1,643 shares of Cardinal Health worth $390K as of Q2 2026.
  • Valmark Advisers sold 469 Cardinal Health shares in Q2 2026, an estimated $97.5K.
  • Cardinal Health made up ﹤0.01% of Valmark Advisers's portfolio in Q2 2026, its #561 holding.
  • Valmark Advisers first reported a position in Cardinal Health in Q2 2025 and has held it in 5 quarters since.
  • Valmark Advisers's Cardinal Health position peaked at $446K in Q1 2026.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Valmark Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.